The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 34.00
Bid: 33.00
Ask: 35.00
Change: 0.00 (0.00%)
Spread: 2.00 (6.061%)
Open: 34.00
High: 34.00
Low: 34.00
Prev. Close: 34.00
MERC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sale of Allinea Software Limited to ARM

16 Dec 2016 07:00

RNS Number : 0500S
Mercia Technologies PLC
16 December 2016
 

RNS

16 December 2016

 

Mercia Technologies PLC

("Mercia", "the Company" or "the Group")

 

Sale of Allinea Software Limited to ARM Limited

 

Mercia Technologies PLC (AIM: MERC), a national investment group focused on the creation, funding and scaling of innovative technology businesses with high growth potential from the UK regions, is pleased to announce the sale of Allinea Software Limited ("Allinea") to ARM Limited ("ARM"), the world's leading semiconductor IP company, for a total cash consideration of up to £18.1million. The sale represents a return of circa 21x on the original investment cost.

 

Allinea, based in Warwick, is a leading provider of software tools for developing and optimising high performance computing applications. This cash exit demonstrates how early-stage businesses can be effectively supported through Mercia's 'Complete Capital Solution'. In 2009, Mercia identified the investment opportunity and led the funding of a management buyout of Allinea from another University of Warwick spinout. Mercia's third party managed funds provided early-stage investment and support. Following a period of successful trading, Allinea then became one of the Group's original direct investments ('Emerging Stars') at the time of Mercia's IPO in December 2014. Mercia's direct holding increased from 6.9% at IPO, to 16.6% as at 30 September 2016 via its purchase of the Mercia Fund 2 investment portfolio in 2015.

 

Allinea's platform is able to address high performance computing software development, debugging and performance optimisation through the use of its core products. Allinea has offices in the United States, Europe and Japan, and its software is used in circa 70% of the world's largest supercomputers. It has built relationships with many notable, blue-chip customers and partners.

 

With backing from Mercia, Allinea was scaled into a profitable, cash generative and dividend paying business over a period of seven years and Allinea's board has now successfully completed a competitive sale process.

 

This first Emerging Star divestment represents a substantial return for Mercia, which will receive initial proceeds of £2.6million (net of transaction expenses) with a further £0.3million held in escrow for up to 18 months in respect of customary closing working capital calculations and potential warranty claims. Mercia will recognise an immediate realised gain of £0.7million, compared with the holding value of £1.9million as at 30 September 2016. Mercia's total investment cost is £1.5million, so the initial proceeds of £2.6million represents a 73% uplift.

 

Dr Mark Payton, CEO of Mercia Technologies PLC, said:

 

"This planned divestment is a pleasing endorsement of Mercia's Complete Capital Solution, showing how Mercia sources and invests in attractive investment opportunities at an early stage. Initially this is undertaken via the managed funds, subsequently scaling those assets through direct investment which have the potential, ultimately, to be acquired by top-tier buyers. The sale of Allinea to ARM is a testament to the value held within our investment portfolio and will enable Allinea to accelerate its development and reach within the growing high performance computing markets, as well as achieving greater exposure in adjacent segments such as machine learning. As a Midlands-based business, this is further evidence of the hidden value we are able to unearth from the UK regions and our university partnerships."

 

For further information, please contact:

Mercia Technologies PLC

Mark Payton, Chief Executive Officer

Martin Glanfield, Chief Financial Officer

www.merciatech.co.uk

 

+44 (0)330 223 1430

 

Cenkos Securities plc

Ivonne Cantu / Mark Connelly (NOMAD)

+44 (0)20 7397 8900

Buchanan

Sophie McNulty, Victoria Hayns, Stephanie Watson

www.buchanan.uk.com

+44 (0)20 7466 5000

 

About Mercia Technologies PLC

Mercia is a national investment group focused on the creation, funding and scaling of innovative businesses with high growth potential from the UK regions. Mercia benefits from 18 university partnerships and six offices across the Midlands, the North of England and Scotland providing it with access to high quality, regional deal flow. Mercia Technologies PLC is quoted on AIM with the epic "MERC".

 

Mercia's 'Complete Capital Solution' initially nurtures businesses via its third party funds (with more than £228.0million under management) and then over time Mercia can provide further funding to its 'Emerging Stars' by deploying direct investment follow-on capital from its own balance sheet.

 

Since its IPO in December 2014, the Company has invested over £30.0million directly across its portfolio of 'Emerging Stars'.

 

About Allinea

Allinea creates powerful development and performance analysis tools that enable developers and users of software in high performance computing to create and deploy applications that achieve the most efficient use of their systems.

 

The company's software is now used in 70% of the world's largest supercomputers. Its customers are the leaders in government supercomputing, such as the US Department of Energy, NOAA, NASA and CEA as well as major Fortune 500 companies including Shell, Emerson, Oracle and Corning, and research groups and educators at universities such as Princeton, Stanford, Cambridge and Edinburgh.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGGGCCPUPQUQQ
Date   Source Headline
3rd May 20249:44 amRNSTransaction in Own Shares
26th Apr 202410:00 amRNSTransaction in Own Shares
25th Apr 20249:29 amRNSTransaction in Own Shares
24th Apr 20249:41 amRNSTransaction in Own Shares
23rd Apr 20249:34 amRNSTransaction in Own Shares
22nd Apr 20249:43 amRNSTransaction in Own Shares
17th Apr 20249:23 amRNSTransaction in Own Shares
16th Apr 20249:44 amRNSTransaction in Own Shares
15th Apr 20249:12 amRNSTransaction in Own Shares
12th Apr 20249:43 amRNSTransaction in Own Shares
11th Apr 20249:35 amRNSTransaction in Own Shares
10th Apr 202411:34 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSYear end trading summary and date of results
9th Apr 20249:38 amRNSTransaction in Own Shares
5th Apr 20249:25 amRNSTransaction in Own Shares
4th Apr 20249:33 amRNSTransaction in Own Shares
3rd Apr 20249:22 amRNSTransaction in Own Shares
28th Mar 202411:41 amRNSTransaction in Own Shares
27th Mar 20249:57 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSGrant and variation of Options
26th Mar 202410:31 amRNSTransaction in Own Shares
25th Mar 202412:24 pmRNSTransaction in Own Shares
22nd Mar 20249:01 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSDirector/PDMR Dealings
21st Mar 20249:14 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSMercia secures two further BBB contracts
20th Mar 20249:32 amRNSTransaction in Own Shares
18th Mar 20249:59 amRNSTransaction in Own Shares
15th Mar 20249:04 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSMercia completes three syndicated funding rounds
13th Mar 202411:24 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSMercia's Northern VCTs raise £60.0million
12th Mar 20249:46 amRNSTransaction in Own Shares
11th Mar 20249:16 amRNSTransaction in Own Shares
8th Mar 202410:14 amRNSTransaction in Own Shares
7th Mar 202410:15 amRNSTransaction in Own Shares
5th Mar 202410:16 amRNSTransaction in Own Shares
4th Mar 20249:44 amRNSTransaction in Own Shares
1st Mar 202410:11 amRNSTransaction in Own Shares
29th Feb 20247:00 amRNSNew British Business Bank contracts
28th Feb 20248:38 amRNSTransaction in Own Shares
27th Feb 20248:44 amRNSTransaction in Own Shares
26th Feb 20248:49 amRNSTransaction in Own Shares
23rd Feb 20249:25 amRNSTransaction in Own Shares
21st Feb 20249:29 amRNSTransaction in Own Shares
16th Feb 20248:59 amRNSTransaction in Own Shares
15th Feb 20249:31 amRNSTransaction in Own Shares
9th Feb 20249:46 amRNSTransaction in Own Shares
8th Feb 20249:41 amRNSTransaction in Own Shares
7th Feb 20249:48 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.